Drug
Adapalene
Adapalene: highest development phase Post-Market, developed by Galderma, Sun Pharma. 4 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Galderma, Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Adapalene NCT00660985 | Post-Market | Acne Vulgaris |
| EPIDUO | Approved | |
| ADAPALENE AND BENZOYL PEROXIDE | Approved | |
| adapalene gel, 0.3% NCT00647556 | Phase 3 | Photoaging |
Latest
No recent events.
Follow Adapalene on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.